
Opinion|Videos|May 29, 2024
Unmet Needs in Relapsed or Refractory Multiple Myeloma
Sarah Rockwell, PharmD, BCOP, and Ke Ning, MD, share their concluding remarks, reflecting on the current landscape and expressing their aspirations for addressing remaining unmet needs.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
3
Higher Ultra-Processed Food Intake Linked to Increased Prediabetes Risk in Young Adults
4
Late-Breaking Data Support Lorundrostat Treatment in Patients With CKD
5





















































































































































































































